GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction

Biological Psychiatry Global Open Science · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles